| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 71.791 | 71.641 | 78.671 | 80.225 | 79.901 | 87.001 | 102.310 | 109.478 | 99.572 | 96.049 |
| Total Income - EUR | 72.865 | 72.547 | 80.095 | 81.191 | 81.717 | 87.997 | 103.580 | 110.400 | 99.871 | 96.051 |
| Total Expenses - EUR | 72.165 | 70.532 | 76.539 | 83.231 | 85.995 | 85.537 | 97.322 | 105.192 | 98.032 | 94.282 |
| Gross Profit/Loss - EUR | 700 | 2.016 | 3.556 | -2.040 | -4.278 | 2.461 | 6.258 | 5.208 | 1.838 | 1.769 |
| Net Profit/Loss - EUR | 485 | 1.106 | 2.755 | -2.828 | -5.095 | 1.827 | 5.222 | 4.104 | 839 | -216 |
| Employees | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Letifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 379 | 274 | 170 | 970 | 972 | 1.658 | 1.045 | 1.870 | 1.164 | 1.575 |
| Current Assets | 16.845 | 11.055 | 17.634 | 21.860 | 18.955 | 21.955 | 25.754 | 30.447 | 42.044 | 25.364 |
| Inventories | 8.709 | 7.510 | 8.507 | 10.752 | 11.925 | 14.652 | 13.494 | 13.033 | 17.195 | 8.615 |
| Receivables | 7.917 | 2.885 | 8.137 | 11.024 | 6.884 | 7.273 | 12.243 | 16.863 | 23.733 | 16.599 |
| Cash | 219 | 660 | 989 | 84 | 146 | 30 | 17 | 550 | 1.117 | 150 |
| Shareholders Funds | -10.889 | -9.672 | -6.754 | -9.457 | -14.369 | -12.270 | -6.775 | -2.692 | -1.845 | -2.051 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.996 | 24.954 | 28.012 | 36.190 | 37.604 | 37.900 | 34.348 | 35.009 | 45.053 | 28.989 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Letifarm Srl